Reproducibility of Published Randomized Controlled Trial Results in Cardiovascular Surgery: Protocol for a Meta-Epidemiological Umbrella Review.

IF 1.6 Q3 HEALTH CARE SCIENCES & SERVICES
Allen Li, Arshia P Javidan, Daniel J Niven, Henry T Stelfox, Dean A Fergusson, Mamas A Mamas, Prasad Jetty, Charles de Mestral, Risa Shorr, Subodh Verma, Munir Boodhwani, Derek J Roberts
{"title":"Reproducibility of Published Randomized Controlled Trial Results in Cardiovascular Surgery: Protocol for a Meta-Epidemiological Umbrella Review.","authors":"Allen Li, Arshia P Javidan, Daniel J Niven, Henry T Stelfox, Dean A Fergusson, Mamas A Mamas, Prasad Jetty, Charles de Mestral, Risa Shorr, Subodh Verma, Munir Boodhwani, Derek J Roberts","doi":"10.2196/93997","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Reproducible study findings are those that are shown to be identical or nearly identical when an original study is repeated using similar methods. Findings from many randomized controlled trials (RCTs) in cardiovascular surgery have not been reproduced or are small, statistically fragile, and potentially influenced by funding source. They also demonstrate variable end point selection and protocol adherence, all of which may influence reproducibility of their reported results.</p><p><strong>Objective: </strong>This study aims to assess the reproducibility of RCTs conducted in the most commonly studied disease states in cardiovascular surgery that compared at least one open surgical procedure to an alternative open, interventional catheter-based, or sham procedure or medical therapy.</p><p><strong>Methods: </strong>We will conduct a meta-epidemiological study of the reproducibility of RCTs using umbrella review methodology. We designed the study protocol using the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) statement and published recommendations on conducting umbrella reviews. We will search MEDLINE, Embase, and the CENTRAL from their inception for systematic reviews published in the English language that included data from phase 3 RCTs or those with a clinically important primary outcome and compared an open cardiovascular surgery (performed in the most commonly studied disease states across these specialties) to either an alternative open, catheter-based, or sham procedure or medical therapy. Two investigators will independently review the individual RCTs from these systematic reviews and extract data and assess risk of bias (using the Cochrane Risk of Bias-2 tool), the fragility or reverse fragility indices (which provide a measurement of the statistical robustness of the trials), and the authors' interpretation of the results (also referred to as spin). RCTs will be classified as the original study if it was the first chronological study (based on participant enrollment date) to evaluate the compared interventions and as reproduction attempts if they reevaluate the compared interventions in a different set of participants. The interpretation of a study's results will be based on the findings of its primary end point and be used to assess reproducibility. We will also create multivariable regression models to determine whether the adjusted odds of reproducibility are independently predicted by 12 different variables.</p><p><strong>Results: </strong>We registered the study protocol but have not yet conducted the search. We aim to complete the study by the end of 2026 and submit for peer review by the summer of 2027.</p><p><strong>Conclusions: </strong>This study protocol may be used as a framework for future reproducibility research. The results will help guide which cardiovascular surgery practices warrant careful interpretation and which are in need of reproduction studies. They will also identify characteristics of an original RCT in this field that predicts future study reproducibility before reproducibility studies are published.</p>","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"15 ","pages":"e93997"},"PeriodicalIF":1.6000,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13641308/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR Research Protocols","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/93997","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Reproducible study findings are those that are shown to be identical or nearly identical when an original study is repeated using similar methods. Findings from many randomized controlled trials (RCTs) in cardiovascular surgery have not been reproduced or are small, statistically fragile, and potentially influenced by funding source. They also demonstrate variable end point selection and protocol adherence, all of which may influence reproducibility of their reported results.

Objective: This study aims to assess the reproducibility of RCTs conducted in the most commonly studied disease states in cardiovascular surgery that compared at least one open surgical procedure to an alternative open, interventional catheter-based, or sham procedure or medical therapy.

Methods: We will conduct a meta-epidemiological study of the reproducibility of RCTs using umbrella review methodology. We designed the study protocol using the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) statement and published recommendations on conducting umbrella reviews. We will search MEDLINE, Embase, and the CENTRAL from their inception for systematic reviews published in the English language that included data from phase 3 RCTs or those with a clinically important primary outcome and compared an open cardiovascular surgery (performed in the most commonly studied disease states across these specialties) to either an alternative open, catheter-based, or sham procedure or medical therapy. Two investigators will independently review the individual RCTs from these systematic reviews and extract data and assess risk of bias (using the Cochrane Risk of Bias-2 tool), the fragility or reverse fragility indices (which provide a measurement of the statistical robustness of the trials), and the authors' interpretation of the results (also referred to as spin). RCTs will be classified as the original study if it was the first chronological study (based on participant enrollment date) to evaluate the compared interventions and as reproduction attempts if they reevaluate the compared interventions in a different set of participants. The interpretation of a study's results will be based on the findings of its primary end point and be used to assess reproducibility. We will also create multivariable regression models to determine whether the adjusted odds of reproducibility are independently predicted by 12 different variables.

Results: We registered the study protocol but have not yet conducted the search. We aim to complete the study by the end of 2026 and submit for peer review by the summer of 2027.

Conclusions: This study protocol may be used as a framework for future reproducibility research. The results will help guide which cardiovascular surgery practices warrant careful interpretation and which are in need of reproduction studies. They will also identify characteristics of an original RCT in this field that predicts future study reproducibility before reproducibility studies are published.

已发表的心血管外科随机对照试验结果的可重复性:元流行病学保护伞评价方案。
背景:可重复的研究结果是指使用类似的方法重复原始研究时显示出相同或几乎相同的结果。许多心血管外科随机对照试验(RCTs)的结果没有被复制,或者是小的、统计上脆弱的,并且可能受到资金来源的影响。他们还展示了可变的终点选择和协议遵守,所有这些都可能影响其报告结果的可重复性。目的:本研究旨在评估在心血管手术中最常见的疾病状态中进行的随机对照试验的可重复性,这些随机对照试验将至少一种开放手术与另一种开放手术、介入性导管手术、假手术或药物治疗进行比较。方法:我们将采用总括性综述方法对随机对照试验的可重复性进行meta流行病学研究。我们使用PRISMA-P(系统评价和荟萃分析方案的首选报告项目)声明设计了研究方案,并发表了关于进行总体性评价的建议。我们将检索MEDLINE、Embase和CENTRAL,从一开始就以英文发表的系统综述,包括来自3期随机对照试验或具有临床重要主要结局的数据,并将开放式心血管手术(在这些专科最常见的疾病状态下进行)与其他开放式、导管手术或假手术或药物治疗进行比较。两名研究人员将独立审查这些系统评价中的单个随机对照试验,提取数据并评估偏倚风险(使用Cochrane risk of bias -2工具)、脆弱性或反向脆弱性指数(提供试验统计稳健性的衡量标准)以及作者对结果的解释(也称为自旋)。如果rct是第一次按时间顺序(基于参与者入组日期)评估比较干预措施的研究,则将其归类为原始研究;如果在不同的参与者中重新评估比较干预措施,则将其归类为复制尝试。对研究结果的解释将基于其主要终点的发现,并用于评估可重复性。我们还将创建多变量回归模型,以确定12个不同变量是否能够独立预测调整后的再现性几率。结果:我们注册了研究方案,但尚未进行检索。我们的目标是在2026年底完成研究,并在2027年夏季提交同行评审。结论:本研究方案可作为未来可重复性研究的框架。结果将有助于指导哪些心血管手术实践值得仔细解释,哪些需要复制研究。他们还将确定该领域原始RCT的特征,在可重复性研究发表之前预测未来研究的可重复性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
5.90%
发文量
414
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书